Figure 4.
Aprataxin binds to a conserved di-phosphorylated CK2 motif in MDC1. (A) MDC1 contains six conserved motifs with a core SDTD motif that is di-phosphorylated in vivo (48–50). (B) ITC binding isotherms for interaction of wild-type aprataxin FHA with pSDTD and SDpTD phosphopeptides (C, D) ITC binding isotherms for the titration of pSDpTD phosphopeptide into wild-type and K38A aprataxin FHA, respectively. (E) Diagram of GFP-MDC1 mutants used in the pull-down assays. (F) Aprataxin FHA GST pull downs from HeLa cells expressing wild-type GFP-MDC1, a mutant containing a deletion of the SDTD region (ΔSDTD), and a mutant where the Thr residues contained in the SDTD sequence were replaced by Ala (SDAD)2.
